Schick hit with shareholder suits
Digital x-ray and bone densitometry developer Schick Technologies of Long Island City, NY, is facing several class-action complaints filed by its shareholders, according to Eli Schick, director of investor relations. The complaints, brought this month by
Digital x-ray and bone densitometry developer Schick Technologies of Long Island City, NY, is facing several class-action complaints filed by its shareholders, according to Eli Schick, director of investor relations. The complaints, brought this month by several law firms, claim that Schick knowingly misstated its financial condition before announcing on Dec. 10 that it would take a one-time charge of $5 million against earnings for its third quarter 1998, ending December (SCAN 1/14/99).
In more positive Schick news, the company received a patent for its accuDEXA bone densitometer on Jan. 8. The Food and Drug Administration cleared the unit in December 1997 (SCAN 1/21/98), and Schick has sold about 2500 of the densitometers. AccuDEXA is priced under $13,000.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
